Evidence map›Paper›PMID 19162564›Full record

ArticleDNA repair2009

DNA repair modulates the vulnerability of the developing brain to alkylating agents.

G E Kisby, A Olivas, T Park, M Churchwell, D Doerge, L D Samson, S L Gerson, M S Turker

Open access · greenAbstract read
In one paragraph

Article in DNA repair, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Animal models of brain maldevelopment induced by cycad plant genotoxins.Birth defects research. Part C, Embryo today : reviews · 2013
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

G E KisbyCenter for Research on Occupational and Environmental Toxicology, Oregon Health & Science University, Portland, OR 97239, United States. kisby@ohsu.edu
A Olivas
T Park
M Churchwell
D Doerge
L D Samson
S L Gerson
M S Turker
Oregon Health & Science University · USNational Center for Toxicological Research · USCase Western Reserve University · USMassachusetts Institute of Technology · US

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARK R CHANCE · 1987 to 2026
$142.3M
IN VIVO ROLE OF DNA ALKYLATION REPAIRR01CA075576 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SAMSON, LEONA D. · 1997 to 2011
$4.9M
TRANSGENIC APPROACH TO ONCOGENE AND DNA REPAIR IMBALANCER01CA063193 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI GERSON, STANTON L · 1994 to 2005
$1.3M
NCI NIH HHS CA075576NCI NIH HHS P30 CA043703NCI NIH HHS R01 CA063193NCI NIH HHS R01 CA075576PHS HHS R01 C63193
6 · The paper itself

Abstract

Neurons of the developing brain are especially vulnerable to environmental agents that damage DNA (i.e., genotoxicants), but the mechanism is poorly understood. The focus of the present study is to demonstrate that DNA damage plays a key role in disrupting neurodevelopment. To examine this hypothesis, we compared the cytotoxic and DNA damaging properties of the methylating agents methylazoxymethanol (MAM) and dimethyl sulfate (DMS) and the mono- and bifunctional alkylating agents chloroethylamine (CEA) and nitrogen mustard (HN2), in granule cell neurons derived from the cerebellum of neonatal wild type mice and three transgenic DNA repair strains. Wild type cerebellar neurons were significantly more sensitive to the alkylating agents DMS and HN2 than neuronal cultures treated with MAM or the half-mustard CEA. Parallel studies with neuronal cultures from mice deficient in alkylguanine DNA glycosylase (Aag(-/-)) or O(6)-methylguanine methyltransferase (Mgmt(-/-)), revealed significant differences in the sensitivity of neurons to all four genotoxicants. Mgmt(-/-) neurons were more sensitive to MAM and HN2 than the other genotoxicants and wild type neurons treated with either alkylating agent. In contrast, Aag(-/-) neurons were for the most part significantly less sensitive than wild type or Mgmt(-/-) neurons to MAM and HN2. Aag(-/-) neurons were also significantly less sensitive than wild type neurons treated with either DMS or CEA. Granule cell development and motor function were also more severely disturbed by MAM and HN2 in Mgmt(-/-) mice than in comparably treated wild type mice. In contrast, cerebellar development and motor function were well preserved in MAM-treated Aag(-/-) or MGMT-overexpressing (Mgmt(Tg+)) mice, even as compared with wild type mice suggesting that AAG protein increases MAM toxicity, whereas MGMT protein decreases toxicity. Surprisingly, neuronal development and motor function were severely disturbed in Mgmt(Tg+) mice treated with HN2. Collectively, these in vitro and in vivo studies demonstrate that the type of DNA lesion and the efficiency of DNA repair are two important factors that determine the vulnerability of the developing brain to long-term injury by a genotoxicant.

Indexed as

CerebellumAlkylating AgentsAnimalsCattleCell SurvivalChickensDNADNA FragmentationDNA GlycosylasesDNA Modification MethylasesDNA RepairDNA Repair EnzymesEthylaminesHumansMechlorethamineMethylazoxymethanol Acetate3-methyladenine-DNA glycosylaseAlkylating Agentsdimethyl sulfateDNADNA GlycosylasesDNA Modification MethylasesDNA Repair EnzymesEthylaminesMechlorethaminemethylazoxymethanolMethylazoxymethanol AcetateMGMT protein, mouseSulfuric Acid EstersTumor Suppressor Proteins

Identifiers

PMID19162564
PMCPMC2692311
OpenAlexW2108559250

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.